Burguin, A.; Roy, J.; Ouellette, G.; Maltais, R.; Bherer, J.; Diorio, C.; Poirier, D.; Durocher, F.
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments. J. Clin. Med. 2023, 12, 4241.
https://doi.org/10.3390/jcm12134241
AMA Style
Burguin A, Roy J, Ouellette G, Maltais R, Bherer J, Diorio C, Poirier D, Durocher F.
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments. Journal of Clinical Medicine. 2023; 12(13):4241.
https://doi.org/10.3390/jcm12134241
Chicago/Turabian Style
Burguin, Anna, Jenny Roy, Geneviève Ouellette, René Maltais, Juliette Bherer, Caroline Diorio, Donald Poirier, and Francine Durocher.
2023. "Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments" Journal of Clinical Medicine 12, no. 13: 4241.
https://doi.org/10.3390/jcm12134241
APA Style
Burguin, A., Roy, J., Ouellette, G., Maltais, R., Bherer, J., Diorio, C., Poirier, D., & Durocher, F.
(2023). Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments. Journal of Clinical Medicine, 12(13), 4241.
https://doi.org/10.3390/jcm12134241